News & Updates

Smith Drug Company Receives the 2018 Distribution Management Award for Cloud-Based Predictive IMS

Mar 6, 2018 Tags: HDMA, Smith Drug Company

Smith Drug Company, Div. J M Smith Corporation, is the winner of the 2018 Distribution Management Award (DMA) for their implementation of a cloud-based predictive inventory management system (IMS). The DMA is awarded annually to HDA member companies that, through a collaborative partnership, enhance the efficiency, effectiveness and safety of the supply chain. Recipients must demonstrate measurable gains in productivity and reduction in costs in addition to implementing innovative technology, processes or programs across trading partners.

Read more

J M Smith Corporation Announces Leadership Team Changes

Feb 26, 2018 Tags: Business, J M Smith Corporation, Smith Drug Company

Saul Factor, RPh named President, Smith Drug Company and Burlington Drug Company; Kevin Welch named President, Integra LTC Solution, LLC and QS/1

SPARTANBURG, S.C. – J M Smith Corporation has announced that its leading innovative technology solutions will now be under the leadership of Kevin Welch. Saul Factor, RPh, who was the President of QS/1, will lead the wholesale distribution business units Smith Drug Company and Burlington Drug Company.

“The decision to align our technology offerings under one leader was made to further enhance our customer focus. Kevin is a highly respected technology leader with a passion for moving pharmacy forward. Under his guidance, QS/1 and Integra customers can expect a commitment to technology excellence and responsiveness,” said Alan Turfe, CEO and Chairman, J M Smith Corporation. “During his time as President of QS/1, Saul led with transparency and a contagious drive to advance customer centricity and business excellence. I am looking forward to what Kevin and Saul will accomplish for our customers in their new roles.

Read more

If You Are Ever Late Filing for Your CE, This New ACPE Policy Will Affect You

Jan 8, 2018 Tags: NCPA

Starting in 2018, there will be a charge of $200 from ACPE for filing for CE after the 60-day submission deadline. NCPA has established "free pass" filing periods for March, August, and December of 2018 where your overdue activities can still be filed at no charge. Please contact Sue Hagler at sue.hagler@ncpanet.org with any questions and activities you need submitted. Have the following information ready: e-Profile ID, DOB (MMDD), and ACPE UAN for each activity.

Read more

Helping the Victims of Hurricane Harvey

Sep 1, 2017 Tags: Business, Smith Drug Company

Hurricane Harvey made its first landfall on the Texas coast at Rockport Friday August 25th as a Category 4 hurricane, and moved back out over the bay before making a second landfall as a Category 3 hurricane. Harvey's intense winds and prolonged heavy rainfall devastated the Texas coast and coastal areas in Louisiana, causing dangerous flooding and spawning tornadoes.

The Smith Drug Operations Team and the SmithPride Committee quickly organized an effort to provide much needed drinking water to the Gulf Coast area. Their goal was to provide 100 cases of water to the affected areas. Smith employees quickly gave from their hearts, donating both cash and supplies to the effort.

Read more

Smith Drug Company Names Associate Vice President of Strategy, Industry Relations

Aug 4, 2017 Tags: Business, J M Smith Corporation, Smith Drug Company

Matt Pike brings extensive pharmacy background to new position

SPARTANBURG, S.C. – Smith Drug Company (SDC) has announced that Matthew Pike has been named to the newly-created position of Associate Vice President of Strategy, Industry Relations. In this role, Pike will work with Smith Drug Company to develop and operationalize strategy designed to maximize efficiencies and market share. Pike will also leverage his background as a resource for industry relations.

“To have someone of Matt’s caliber on our team is a tremendous asset,” said Jeff Foreman, RPh, President, Smith Drug Company. “Matt brings a great deal of experience and knowledge of the industry. Our team has tremendous depth and expertise already, but Matt’s arrival strengthens it even more. Smith Drug Company is poised for success against the challenges that lie ahead, and our customers will benefit from this.”

Read more